Summary : – Medikabazaar, an online B2B platform for medical supplies, is looking to achieve a gross merchandise value (GMV) of around…
company
-
-
RegulatoryU.S FDA
Roche COVID-19 At-Home Test Granted FDA Emergency Use Authorization to expand access to Rapid Self-Testing Solutions in the United States
by adminby adminSummary : Rapid test to support the American public’s fight against the COVID-19 pandemic, with availability to purchase over-the-counter (OTC) at pharmacies…
-
AgrochemicalsCompaniesGlobal MarketPharma Science & Research
Takeda’s Eohilia Suffers Another Set Back FDA rejection after Mysterious Delay
by adminby adminSynopsis: -The FDA recommended Takeda run an additional clinical study to resolve its questions around Eohilia, an oral suspension formulation of the…
-
AgrochemicalsGlobal Market
PDS Biotech Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
by adminby adminSynopsis: PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology company pioneering the development of novel multifunctional immunotherapeutic products, today announced…
-
AgrochemicalsArgenx
Argenx Snags First US. FDA Approval With Vyvgart (efgartigimod alfa-fcab) win in Generalized Myasthenia Gravis
by adminby adminSynopsis: VYVGART is the first-and-only FDA-approved neonatal Fc receptor blocker 68% of anti-acetylcholine receptor (AChR) antibody positive gMG patients treated with VYVGART…
-
AgrochemicalsGlobal Market
BCI Pharma Collaborated with Mithra to Identify Novel Therapy for Endometriosis and Cancer in Women.
by adminby adminSynopsis : BCI Pharma and Mithra will start a collaboration to deliver new therapy for women! Mithra acquires the right relating to…
-
Agrochemicals
Aptinyx Set in Motion Phase 2b Study of NYX-783 in Patients with Post-Traumatic Stress Disorder
by adminby adminSynopsis: Aptinyx Inc., a clinical-stage biopharmaceutical company, announced the initiation of a phase 2b study evaluating 50 mg QD of NYX-783 in…
-
AgrochemicalsGlobal MarketIndia
Alembic Pharma under Pressure as USFDA Issues Form 483 to Gujarat Plant
by adminby adminSynopsis: Alembic Pharma share price fell over 4 percent in intraday trade on December 16 following reports that the US Food and…
-
Synopsis: The EMA’s human medicines committee has said it cannot approve Biogen and Eisai’s Alzheimer’s disease therapy Aduhelm, saying it was unconvinced…
-
Synopsis – – Vineet Gupta joined Eli Lilly in 2010 as Marketing Director for India, followed by a role as Corporate Affairs…